release

Curio and Deep Isolation Sign MOU to Advance Nuclear Waste Disposal Technologies.

Source Node:
Time Stamp: December 7, 2023 3:23 PM - Modified On: December 7, 2023 - Published By:
Source Cluster:
Republished By Plato

Washington, D.C, December 7, 2023 — Curio, a trailblazer in nuclear technology solutions, and Deep Isolation, an innovator in nuclear waste disposal, have entered into a Memorandum of Understanding (MOU) to collectively drive forward the development of advanced technologies for efficient and secure disposal of high-level nuclear waste (HLW). Under this MOU, both Curio and Deep Isolation will mutually collaborate and exchange critical information for the use of Deep Isolation’s Universal Canister System (UCS) and patented directional drilling solution for deep borehole disposal for the isolation and management of HLW

BitMask Wallet 0.7.0 Soars: A Quantum Leap in Bitcoin Evolution Surges Over 760,000 Wallets in Just One Month

Source Node:
Time Stamp: November 24, 2023 12:02 PM - Modified On: November 24, 2023 - Published By:
Source Cluster:
Republished By Plato

SAN FRANCISCO, November 23, 2023 (ACN Newswire) - DIBA Global, backed by industry titans including Draper Associates, ACTAI Ventures, Waterdrip Capital, Martial Eagle Fund, Brad Mills, Rodney Yesep, and others, has sent shockwaves through the Bitcoin industry with the beta release of BitMask Wallet 0.7.0. This marks a historic moment as the user base surpasses 763,623 wallets. This milestone, achieved without any advertising, underscores the community's trust in DIBA's commitment to advancing Bitcoin utility. Worthy of note is the official partnership between DIBA GLOBAL and Satoshi Lab to foster the development

Verofax wins GITEX Supernova Web3 & Blockchain Award 2023

Source Node:
Time Stamp: October 31, 2023 2:23 PM - Modified On: October 31, 2023 - Published By:
Source Cluster:
Republished By Plato

DUBAI, Nov 1, 2023 - (ACN Newswire) - Verofax, an innovator in Brand & Retail solutions, was selected among 521 startups globally as the best solution offering for Web3 & Blockchain, at the GITEX 2023 Expo,  Supernova Challenge in Dubai. Verofax, a UAE-based startup and service provider for turning shopping & products interactive, has emerged as the winner of the 2023 Supernova Challenge at Expand North Star Dubai, the world's largest startup event. The startup received the prize after rounds of pitching against global finalists. Verofax's groundbreaking solution combines interactive Product

NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimer’s Disease Treatment.

Source Node:
Time Stamp: October 24, 2023 11:55 AM - Modified On: October 24, 2023 - Published By:
Source Cluster:
Republished By Plato

Summary: Progress in Neurodegenerative Research:  NKGen’s Phase 1/2a Clinical Trial for SNK01 on Track for End-of-Year Initiation SANTA ANA, Calif., Oct. 24, 2023 (Plato / Amplifi) -- Today, NKGen Biotech Inc. (Nasdaq: NKGN), a trailblazer in the field of autologous, allogeneic, and CAR-NK natural killer cell therapeutics, proudly announced the progression of its SNK01 program targeting Alzheimer’s Disease (AD), backed by the green light from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application. NKGen is gearing up to initiate its Phase 1/2a clinical trial

Government Blockchain Association (GBA) Releases Voting Solution Assessment Model

Source Node:
Time Stamp: October 20, 2023 7:17 AM - Modified On: October 20, 2023 - Published By:
Source Cluster:
Republished By Plato

  Washington, DC, September 19 — The Government Blockchain Association (GBA) announces the release of the Blockchain Maturity Model (BMM) Voting Supplement. "The Voting Supplement is a critical resource for governments, organizations, and developers worldwide, providing a comprehensive framework to ensure the privacy, security, and integrity of voting systems," said Susan Eustis, Chair of the GBA Voting Working Group. "Its scope extends beyond government elections, making it applicable businesses, associations and other forms of governance, enhancing trust in democratic outcomes." The supplement is a roadmap for developers and administrators seeking

Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases

Source Node:
Time Stamp: October 13, 2023 5:17 AM - Modified On: October 13, 2023 - Published By:
Source Cluster:
Republished By Plato

  In the United States, heart disease accounts for a significant number of deaths every year, with cardiovascular disease being the primary concern. Factors like lifestyle choices and unforeseen circumstances contribute to its prevalence. Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the heart's lining) are two inflammatory heart conditions primarily linked to immunological reactions from viral infections and mRNA vaccines. Though considered rare, awareness of these conditions is growing, especially among younger populations. Recent research in Science Immunology highlighted an increase in cytokine production leading to myocarditis

Zero-G Racetrack Rides into New Territory with Electro-Western Anthem “Never Ride Alone”

Source Node:
Time Stamp: October 6, 2023 12:19 PM - Modified On: October 6, 2023 - Published By:
Source Cluster:
Republished By Plato

[Silicon Valley, October 6, 2023] - Zero-G Racetrack, Silicon Valley’s up and coming Electronic Rock artists, are back with their latest single, "Never Ride Alone”, seamlessly combining the storytelling of classic country western legends with the retro-future allure of Electronic Rock. Zero-G Racetrack has been gaining recognition for their unique approach of using various genre callbacks within the context of electronic dance music. With “Never Ride Alone”, Zero-G Racetrack tips their hat to the compelling Western tales spun by legends like Johnny Cash and Waylon Jennings, setting out to bring

Nutriband’s Innovative Patent Breaks New Ground in Transdermal Medications

Source Node:
Time Stamp: September 20, 2023 8:36 AM - Modified On: September 20, 2023 - Published By:
Source Cluster:
Republished By Plato

Revolutionary AVERSA™ Technology Sets New Standard for Opioid Patch Safety ORLANDO, FL / September 20, 2023 - Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a leading developer of transdermal pharmaceutical products, proudly announces the issuance of a U.S. patent for its cutting-edge AVERSA™ Technology. This groundbreaking innovation, utilizing taste aversion, marks a paradigm shift in addressing the primary routes of abuse associated with opioid-based transdermal patches. The newly granted patent, numbered U.S. patent 11,759,431, titled "Abuse and Misuse Deterrent Transdermal Systems," significantly bolsters Nutriband's intellectual property protection in the United States. It covers

American Picture House Corporate Update

Source Node:
Time Stamp: September 6, 2023 4:28 PM - Modified On: September 6, 2023 - Published By:
Source Cluster:
Republished By Plato

New York, NY, Raleigh, NC, and Los Angeles, CA.  September 6, 2023 – American Picture House Corporation (OTC: APHP), an entertainment company with a focus on producing feature films, limited series, and entertainment enhancing technologies, today provided a corporate update for shareholders. Industry Strikes American Picture House supports the ideals behind the two current industry strikes -- brought by the Writers Guild of America (“WGA”) and the Screen Actors Guild (“SAG”) -- and joins the many reasonable voices urging for a fair and timely resolution. Update on Feature Films -

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Source Node:
Time Stamp: August 29, 2023 8:20 AM - Modified On: August 29, 2023 - Published By:
Source Cluster:
Republished By Plato

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against Parkinson's disease (PD). The Company's lead drug candidate, GT-02287, has demonstrated extraordinary potential in mitigating the effects of Parkinson's disease across two distinct preclinical models of the ailment. These findings suggest that GT-02287 has the capacity to alleviate Parkinson's disease pathology and enhance motor function. A notable highlight is the substantial reduction of plasma Neurofilament Light Chain (NfL) levels, an emerging biomarker for neurodegeneration. This advancement

Livento Group, Inc. Announces Second Quarter Results with Revenue Growth of Over 90%, Including Significant Achievements and Updates

Source Node:
Time Stamp: August 17, 2023 3:06 PM - Modified On: August 17, 2023 - Published By:
Source Cluster:
Republished By Plato

NEW YORK, NY / August 14, 2023 / NuGene International, Inc./Livento Group, Inc. (OTC Pink:NUGN), a dynamic leader specializing in the acquisition and development of companies with disruptive business models in film, content, and technology sectors, is pleased to announce revenue growth of 91.65% for the second quarter of 2023, compared to the same period in 2022. Financial Highlights: Revenue Growth:The second quarter ending June 30, 2023, saw revenues of $431,184, up from $224,986 in 2022. For the six-month period ending June 30, 2023, revenues grew from $680,202 to $922,651, a growth of

Ex-Singapore Parliamentarian’s Swiss Company Launches Swiss Franc and Euro Stablecoins

Source Node:
Time Stamp: August 16, 2023 7:51 AM - Modified On: August 16, 2023 - Published By:
Source Cluster:
Republished By Plato

Singapore investor and former parliamentarian Calvin Cheng's newly rebranded Swiss company, Anchored Coins, was granted membership in the Swiss VQF in early 2023. VQF is the largest and oldest cross-industry self-regulatory organisation in Switzerland and is officially recognised by FINMA, the country's financial services watchdog. Anchored Coins is launching a Swiss Franc-backed stablecoin (ACHF) and a Euro-backed stablecoin (AEUR), and will be issued on the Ethereum and BNB Chain blockchains. DCS Card Centre in Singapore is planning to issue credit cards collateralised by AEUR and ACHF. ZURICH, SWITZERLAND, Aug 16,